Stardust Pharmaceutical Private Limited
About Stardust Pharmaceutical Private Limited
Data last updated:
Stardust Pharmaceutical Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24231RJ2020PTC070830.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rashmi Gandhi and Vishal Kumar Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P. No. A – 5 South Part Golyawas Bahubali Nagar Sanganer, Jaipur, Rajasthan, India – 302029.
As per the financials filed for FY 2025, the company reported a revenue of ₹48.07 Lakh, a growth of 27% compared to the previous year. For the same year it recorded a net profit of ₹1.74 Lakh (net margin 3.6%) and EBITDA of ₹4.8 Lakh (EBITDA margin 10%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years.
As per MCA filings, the company has open charges of ₹10.14 Lakh on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressP. No. A – 5 South Part Golyawas Bahubali Nagar Sanganer, Jaipur, Rajasthan, India – 302029
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Stardust Pharmaceutical Private Limited
The main business activity of Stardust Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Stardust Pharmaceutical Private Limited FY 2025 filings available
Stardust Pharmaceutical Private Limited reported revenue of ₹48.07 Lakh (up 27% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Stardust Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 19% over three years, including 27% growth in the latest year. EBITDA rose 244% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Stardust Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.8 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.74 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Stardust Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Stardust Pharmaceutical are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Stardust Pharmaceutical Private Limited
Stardust Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gajanand Multicom Private Limited | ₹48.07 Lakh (FY 2024) | •••• | •••• | -34.0% | •••• | Kolkata, West Bengal, India |
| Kwality Era India Private Limited | ₹48.07 Lakh (FY 2024) | •••• | •••• | 462.0% | •••• | Hisar, Haryana, India |
| Tulips Services Private Limited | ₹48.07 Lakh (FY 2016) | •••• | •••• | 53.0% | •••• | New Delhi, Delhi, India |
| Swastik Bone and Gelatines Private Limited | ₹48.07 Lakh (FY 2025) | •••• | •••• | 80.0% | •••• | Unnao, Uttar Pradesh, India |
| Atrend Vehicle Accessories Private Limited | ₹48.07 Lakh (FY 2016) | •••• | •••• | 51.0% | •••• | Amritsar, Punjab, India |
| Stardust Pharmaceutical Private Limited this company | ₹48.07 Lakh (FY 2025) | •••• | •••• | 27.0% | •••• | Jaipur, Rajasthan, India |
| Arps India Private Limited | ₹48.06 Lakh (FY 2025) | •••• | •••• | -38.0% | •••• | Patna, Bihar, India |
| Pink City Engimake Private Limited | ₹48.06 Lakh (FY 2025) | •••• | •••• | 105.0% | •••• | Jaipur, Rajasthan, India |
| Gurubaba Enterprises Private Limited | ₹48.05 Lakh (FY 2022) | •••• | •••• | -29.0% | •••• | Latur, Maharashtra, India |
| Rites & Jones Petrochemicals Private Limited | ₹48.05 Lakh (FY 2025) | •••• | •••• | -96.0% | •••• | New Delhi, Delhi, India |
| Bhrigu Traders Private Limited | ₹48.05 Lakh (FY 2020) | •••• | •••• | -31.0% | •••• | Agra, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Stardust Pharmaceutical by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Stardust Pharmaceutical Private Limited
Stardust Pharmaceutical has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rashmi Gandhi Also directs: Statuesque Labs Private Limited | Director | 20 Sep 2025 | 1 Years 0 Months | Current |
| Vishal Kumar Sharma | Director | 20 Sep 2025 | 1 Years 0 Months | Current |
| Manisha Parihar | Director | 20 Sep 2025 | 1 Years 0 Months | Current |
Charges & Borrowings of Stardust Pharmaceutical Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Apr 2021 | Hdfc Bank Limited | ₹10.14 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Stardust Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Stardust Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Stardust Pharmaceutical Private Limited
Stardust Pharmaceutical Private Limited has 6 board changes on record since 2020: 5 appointments and 1 cessation. The latest: Manisha Parihar was appointed as Director on 20 Sep 2025.
Credit Ratings, Litigation & Regulatory Alerts for Stardust Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Stardust Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Stardust Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Stardust Pharmaceutical Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Stardust Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Stardust Pharmaceutical Private Limited
Stardust Pharmaceutical is an active private limited company based in Jaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 September 2020 (6+ years old) and is registered under CIN U24231RJ2020PTC070830.
Stardust Pharmaceutical reported revenue of ₹48.07 Lakh for FY 2025 (up 27% YoY).
Stardust Pharmaceutical has 3 current directors:
- Rashmi Gandhi - Director
- Vishal Kumar Sharma - Director
- Manisha Parihar - Director
Stardust Pharmaceutical reported a net profit of ₹1.74 Lakh (net margin 3.6%) and EBITDA of ₹4.8 Lakh (EBITDA margin 10%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Stardust Pharmaceutical is 19% over three years. In the latest year (FY 2025) revenue rose 27%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Stardust Pharmaceutical is U24231RJ2020PTC070830. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stardust Pharmaceutical was incorporated on 05 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Stardust Pharmaceutical by revenue are Gajanand Multicom Private Limited, Kwality Era India Private Limited, Tulips Services Private Limited, Swastik Bone and Gelatines Private Limited, Atrend Vehicle Accessories Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Manisha Parihar was appointed as Director on 20 Sep 2025. Rashmi Gandhi was appointed as Director on 20 Sep 2025. Vishal Kumar Sharma was appointed as Director on 20 Sep 2025. Stardust Pharmaceutical has 6 board changes on record in total.
The registered office of Stardust Pharmaceutical is at P. No. A – 5 South Part Golyawas Bahubali Nagar Sanganer, Jaipur, Rajasthan, India – 302029.
Stardust Pharmaceutical has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.